InvestorsHub Logo
Followers 18
Posts 932
Boards Moderated 0
Alias Born 04/26/2016

Re: floydborga post# 3488

Thursday, 08/17/2017 5:27:45 PM

Thursday, August 17, 2017 5:27:45 PM

Post# of 12378
I do, for a clinical stage bio very early in Ph1 trials. More dilution via public offerings is inevitable for these types of companies as they hopefully progress with successful results. Even with lucrative partnerships, there's always dilution. I wouldn't be surprised to see a R/S at some point.